ProjectHY-133, a recombinant phage lysin

Basic data

Title:
HY-133, a recombinant phage lysin
Duration:
01/07/2024 to 30/06/2026
Abstract / short description:
Manufacture and phase I clinical trial of HY-133, a recombinant phage lysin for rapid decolonization of Staphylococcus aureus from nasal habitats

Involved staff

Managers

Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
Cluster of Excellence: Controlling Microbes to Fight Infections (CMFI)
Centers or interfaculty scientific institutions

Contact persons

Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes

Other staff

Faculty of Medicine
University of Tübingen
Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes

Local organizational units

Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
University of Tübingen

Funders

Braunschweig, Niedersachsen, Germany
Help

will be deleted permanently. This cannot be undone.